These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

86 related items for PubMed ID: 2933983

  • 21. Oral contraceptive and postmenopausal estrogen effects on lipoprotein triglyceride and cholesterol in an adult female population: relationships to estrogen and progestin potency.
    Knopp RH, Walden CE, Wahl PW, Hoover JJ, Warnick GR, Albers JJ, Ogilvie JT, Hazzard WR.
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1123-32. PubMed ID: 7298796
    [Abstract] [Full Text] [Related]

  • 22. [Progestins and arterial disease].
    Rozenbaum H.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):344-52. PubMed ID: 12280205
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Carbohydrate metabolism in Gynanovlar 21 and Lyndiol 2.5 users.
    Kamal I, Zaki K, Rashad S.
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):67-77. PubMed ID: 12256028
    [Abstract] [Full Text] [Related]

  • 25. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
    Teichmann A.
    Int J Fertil Menopausal Stud; 1995 Jun; 40 Suppl 2():98-104. PubMed ID: 8574257
    [Abstract] [Full Text] [Related]

  • 26. [Lipids, lipoproteins, arterial accidents and oral contraceptives].
    Bakir R, Hilliquin P.
    Contracept Fertil Sex (Paris); 1986 Jan; 14(1):81-7. PubMed ID: 12341243
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. [Hormonal contraception].
    Prilepskaia VN.
    Akush Ginekol (Mosk); 1991 Dec; (12):63-7. PubMed ID: 1789355
    [Abstract] [Full Text] [Related]

  • 29. Update on the metabolic effects of steroidal contraceptives.
    Sondheimer SJ.
    Endocrinol Metab Clin North Am; 1991 Dec; 20(4):911-23. PubMed ID: 1778182
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Norgestrel, increased lipids: fact or "marketing monster"?
    Contracept Technol Update; 1989 Oct; 10(10):133-8. PubMed ID: 12342586
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Do's and don'ts for a woman who has an abnormal lipid pattern and is taking oral contraceptives].
    Boyet F.
    Contracept Fertil Sex (Paris); 1984 Sep; 12(9):1076-7. PubMed ID: 12266510
    [Abstract] [Full Text] [Related]

  • 34. Desogestrel-ethinylestradiol, an oral monophasic contraceptive. Clinical and lipid metabolic effects: a 5-year experience.
    Rubio-lotvin B, Ruiz-moreno JA, Gonzalez-ansorena R.
    Adv Contracept Deliv Syst; 1992 Sep; 8(1-2):75-88. PubMed ID: 12285566
    [Abstract] [Full Text] [Related]

  • 35. [Oral contraceptives and blood platelets].
    Davenas E, Ciavatti M, Poitevin B, Aubin M.
    Homeopath Fr; 1985 Sep; 73(5):299-305. PubMed ID: 12281246
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. [The triphasic pill].
    Belaisch J.
    Contracept Fertil Sex (Paris); 1985 Jan; 13(1 Suppl):368-72. PubMed ID: 12280209
    [Abstract] [Full Text] [Related]

  • 39. Liver function tests in patients on oral progestogens.
    Engineer AD, Gupta V, Tandon P.
    J Obstet Gynaecol India; 1968 Apr; 18(2):598-605. PubMed ID: 12331828
    [Abstract] [Full Text] [Related]

  • 40. Oestriol deficiency, a possible factor in the aetiology of thrombo-embolism in pill users.
    Zaki K, Sami G, Nour H.
    Egypt Popul Fam Plann Rev; 1972 Jun; 5(1):19-24. PubMed ID: 12256026
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.